Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Day

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|September 1, 1988
A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteersS E Tett, D J Cutler, R O Day, et al.
British Journal of Clinical Pharmacology|June 1, 1989
Bioavailability of hydroxychloroquine tablets in healthy volunteersS E Tett, D J Cutler, R O Day, et al.
Agents and Actions|October 1, 1977
The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cellsR O Day, P D Paull, J E Ray, et al.
The Medical Journal of Australia|June 5, 1998
The death of a healthy volunteer in a human research project: implications for Australian clinical researchR O Day, D R Chalmers, K M Williams, et al.
Climacteric : the Journal of the International Menopause Society|July 5, 2003
Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal womenB G Wren, R O Day, A J McLachlan, et al.
Chirality|January 1, 1992
The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the ratB Zhao, G Geisslinger, I Hall, et al.
Clinical Pharmacokinetics|April 5, 2000
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitorN M Davies, A J McLachlan, R O Day, et al.
British Journal of Rheumatology|March 1, 1994
Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritisA J McLachlan, S E Tett, D J Cutler, et al.
Chirality|January 1, 1994
Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemateS E Tett, A J McLachlan, D J Cutler, et al.
Drugs|December 1, 1988
Variability in response to NSAIDs. Fact or fiction?R O Day, G G Graham, K M Williams, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|September 1, 1988
A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteersS E Tett, D J Cutler, R O Day, et al.
British Journal of Clinical Pharmacology|June 1, 1989
Bioavailability of hydroxychloroquine tablets in healthy volunteersS E Tett, D J Cutler, R O Day, et al.
Agents and Actions|October 1, 1977
The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cellsR O Day, P D Paull, J E Ray, et al.
The Medical Journal of Australia|June 5, 1998
The death of a healthy volunteer in a human research project: implications for Australian clinical researchR O Day, D R Chalmers, K M Williams, et al.
Climacteric : the Journal of the International Menopause Society|July 5, 2003
Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal womenB G Wren, R O Day, A J McLachlan, et al.
Chirality|January 1, 1992
The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the ratB Zhao, G Geisslinger, I Hall, et al.
Clinical Pharmacokinetics|April 5, 2000
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitorN M Davies, A J McLachlan, R O Day, et al.
British Journal of Rheumatology|March 1, 1994
Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritisA J McLachlan, S E Tett, D J Cutler, et al.
Chirality|January 1, 1994
Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemateS E Tett, A J McLachlan, D J Cutler, et al.
Drugs|December 1, 1988
Variability in response to NSAIDs. Fact or fiction?R O Day, G G Graham, K M Williams, et al.
Pageof 19